BISOMNA Pre-Order

Investment opportunity

A $25B market — ready for a calmer answer.

Bisomna™ enters the U.S. sleep-aids market as millions look for effective, natural alternatives to traditional sleep aids.

Request Investor Deck$200K pre-seed
$25BU.S. market potentialPer year
$4BTexas & California focusPer year — launch segment
70MAmericans with sleep disordersTarget audience
19.5MAffected in TX & CAInitial focus states

Market growth

A Growing Global Need

The global sleep-aids market and the therapeutic weighted-blanket segment are both compounding — projections in billions USD.

Global sleep-aids market

Billions USD — 6.1% CAGR (2024 → 2034)

$84.6B
$95.2B
$107.2B
$120.7B
$135.9B
$155.3B
Global sleep-aids market — $84.6B (2024) → $155.3B (2034)

Adjacent segment — therapeutic weighted blankets: $1.3B (2024) → $2.2B (2032), 7% CAGR.

Market opportunity

From TAM to Our Target

From the full U.S. opportunity down to our concrete five-year plan — sized honestly. Projections, not promises.

TAM — U.S. market

$25B / year

SAM — Texas & California

$4B / year
Our 5-year target

SOM — 2026–2031

$34.4M cumulative revenue

5-year revenue forecast

Revenues per year — Y1–2 CA & TX · Y3–5 national

$420K
$1.6M
$4.5M
$9.3M
$18.3M

End of Year 5 market share: 0.23% of CA & TX · 0.06% of the rest of the U.S.

Positioning

Competitive Landscape

How Bisomna™ compares with existing solutions across critical success factors (internal analysis).

RF shielding 95%

Bisomna™95
Eight Sleep10
ChiliSleep5
Gravity5

Advanced temperature regulation 85%

Bisomna™85
Eight Sleep90
ChiliSleep80
Gravity20

Living / natural materials 98%

Bisomna™98
Eight Sleep15
ChiliSleep10
Gravity55

Depth of validation protocol 96%

Bisomna™96
Eight Sleep70
ChiliSleep45
Gravity35

Smart home integration 80%

Bisomna™80
Eight Sleep85
ChiliSleep40
Gravity5

Investment opportunity

Pre-Seed — investment ask

Funding to take Bisomna from a validated concept to a working, lab-verified, piloted product.

Pre-seed round

Raise and deployment

$200Ktarget raise — open now

  • Prototype development — Core & PRO
  • Lab verification & biological materials R&D
  • Pilot production — 50 units
  • Product design, brand & marketing foundation
Outcome2 lab-validated models · first U.S. pilot
Next roundsSeed Q3 2027 · Round A Q3 2029

Use of funds

Allocation of the $200K raise

Prototype development25%
Biological materials R&D20%
Lab verification15%
Product design15%
Pilot production (50 units)15%
Brand & marketing10%

All market sizes, projections, returns and timelines on this page are forward-looking estimates prepared by the company — not guarantees of performance.

Join Us in Building Calmer Nights

Partner with us to reshape sleep technology and address a large, converging market opportunity.